The costs of breast cancer treatment can impose a significant financial burden on survivors. The Susan G. Komen® National Treatment Assistance Fund helps bridge the gap for individuals who are actively undergoing breast cancer treatment.
The aim of the National Treatment Assistance Fund is to increase the number of individuals who remain in the breast cancer continuum of care by providing financial assistance to ensure adherence and completion of breast cancer treatment. Funding helps individuals of any age who have been diagnosed with breast cancer, at any stage of the disease.
The fund provides two types of financial assistance – assistance grants and co-pay – based upon need and eligibility requirements. Komen is currently funding two organizations that provide assistance through the National Treatment Assistance Fund. To learn more about these programs click here or call the Komen Breast Care Helpline at 1-877 GO KOMEN (1-877-465-6636).
Limited financial assistance grants are awarded to low-income, underinsured or uninsured individuals across the country including the District of Columbia in need of:
Pain and anti-nausea medication
Lymphedema support and supplies with a prescription
Durable medical equipment ordered by their physician
Transportation to and from treatment
Childcare and/or eldercare necessitated by treatment
Oral medication for cancer treatment
Financial assistance is granted to individuals who meet pre-determined eligibility criteria.
Metastatic breast cancer is breast cancer that has spread beyond the breast to other organs in the body. In the U.S., most women with metastatic cancer develop it when cancer returns at some point after their initial breast cancer diagnosis and treatment.
In October 2013, Susan G. Komen® joined forces with a number of other cancer charities and advocacy groups to form the Metastatic Breast Cancer Alliance (MBC Alliance). Since that time, the MBC Alliance has grown to include 40 members and has made progress against three overarching goals:
Advocate for progress in research that will extend life, enhance quality of life, and ultimately end death from metastatic breast cancer
Strive to ensure that all metastatic breast cancer patients and their caregivers know how to, and are able to access the care and services they need from a responsive and well-informed healthcare system
Educate those diagnosed, their families, healthcare providers, researchers, and health policy influencers and makers on metastatic breast cancer and how it differs from early-stage breast cancer